Edition:
India

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (0874.HK)

0874.HK on Hong Kong Stock

34.95HKD
10:32am IST
Change (% chg)

HK$-0.10 (-0.29%)
Prev Close
HK$35.05
Open
HK$35.15
Day's High
HK$35.25
Day's Low
HK$34.80
Volume
434,000
Avg. Vol
1,988,069
52-wk High
HK$42.10
52-wk Low
HK$23.20

Latest Key Developments (Source: Significant Developments)

Guangzhou Baiyunshan Pharmaceutical Says Chen Mao Resigned As Vice Chairperson
Friday, 31 May 2019 

May 31 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::CHEN MAO RESIGNED AS AN EXECUTIVE DIRECTOR AND VICE CHAIRPERSON OF CO.  Full Article

Guangzhou Baiyunshan Pharmaceutical's Q1 Net Profit Up 55.4 Percent Y/Y
Sunday, 28 Apr 2019 

April 28 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd 0874.HK<600332.SS>::SAYS Q1 NET PROFIT UP 55.4 PERCENT Y/Y.  Full Article

Guangzhou Baiyunshan Pharma's 2018 Net Profit Up 66.9 Percent Y/Y At 3.4 Billion Yuan
Sunday, 17 Mar 2019 

March 17 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd 0874.HK<600332.SS>::SAYS 2018 NET PROFIT UP 66.9 PERCENT Y/Y AT 3.4 BILLION YUAN ($506.49 million).  Full Article

Guangzhou Baiyunshan Pharmaceutical Sees 2018 Net Profit Up 57.6-89.2 Percent Y/Y
Wednesday, 30 Jan 2019 

Jan 30 (Reuters) - Guangzhou Baiyunshan Pharmaceutical <600332.SS>0874.HK::SAYS IT SEES 2018 NET PROFIT UP 57.6-89.2 PERCENT Y/Y FROM 2.06 BILLION YUAN ($306.74 million) YEAR EARLIER.  Full Article

Guangzhou Baiyunshan Pharmaceutical's 9-Month Net Profit Up 131.5 Percent Y/Y
Monday, 29 Oct 2018 

Oct 29 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS 9-MONTH NET PROFIT UP 131.5 PERCENT Y/Y.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate
Tuesday, 24 Jul 2018 

July 24 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS> ::* Says its wholly owned subsidiary received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration .* Certificate issued small-volume injection manufactured by the unit and the valid period is until June 26, 2023.  Full Article

Guangzhou Baiyunshan Pharmaceutical's Unit Signs Framework Agreement On Production Expansion Project
Wednesday, 4 Jul 2018 

July 4 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS UNIT SIGNS FRAMEWORK AGREEMENT ON PRODUCTION EXPANSION PROJECT WITH INVESTMENT OF ABOUT 800 MILLION YUAN ($120.65 million).  Full Article

Guangzhou Baiyunshan Pharmaceutical Updates On Acquisition
Friday, 13 Apr 2018 

April 13 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings <600332.SS>::RECEIVED LETTER OF NO FURTHER REVIEW FROM ANTI-MONOPOLY BUREAU OF MINISTRY OF COMMERCE OF PRC.PROPOSED ACQUISITION NOT SUBJECT TO FURTHER REVIEW, CO MAY PROCEED WITH ACQUISITION FROM APRIL 9.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate
Monday, 5 Mar 2018 

March 5(Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says co's unit Guangzhou Baiyunshan Tianxin Pharmaceutical Co Ltd received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration, for powder-injection, small-volume injection, tablet, hard capsule, dry suspension and granule.Says the valid period is until Feb. 22, 2023.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says Guangzhou-based pharmacy unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration .Certificate issued to oral dosage, Cephalospora capsule, sirup, granules and tablet manufactured by the unit and the valid period is until Dec. 19, 2022.  Full Article